Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.99%598.9B | 3.94%2.51T | 12.19%623.8B | -2.63%2.41T | 12.99%626.53B | -7.85%600.85B | -3.60%631.26B | -10.11%556.01B | 18.05%2.48T | 0.42%554.52B |
| Cost of revenue | -4.13%516.66B | 3.55%2.16T | 11.50%538.91B | -2.50%2.09T | 13.02%542.91B | -9.62%515.91B | -4.02%546.54B | -7.34%483.33B | 17.10%2.14T | 1.88%480.36B |
| Gross profit | -3.12%82.24B | 6.39%346.79B | 16.81%84.89B | -3.44%325.96B | 12.77%83.62B | 4.64%84.94B | -0.75%84.72B | -24.99%72.68B | 24.42%337.57B | -8.07%74.15B |
| Operating expense | 6.96%69.52B | 13.22%271.06B | 25.58%65B | 8.81%239.41B | 10.98%68.03B | 14.85%60.7B | 10.96%58.92B | -1.93%51.76B | 18.29%220.03B | 9.80%61.3B |
| Selling and administrative expenses | 8.09%70.23B | 11.78%269.9B | 17.13%64.97B | 8.39%241.46B | 8.01%65.67B | 7.39%60.57B | 10.44%59.75B | 7.79%55.47B | 23.55%222.77B | 20.99%60.81B |
| -General and administrative expense | 8.09%70.23B | 11.78%269.9B | 17.13%64.97B | 8.39%241.46B | 8.01%65.67B | 7.39%60.57B | 10.44%59.75B | 7.79%55.47B | 23.55%222.77B | 20.99%60.81B |
| Other operating expenses | -15.11%2.26B | 4.41%12.87B | 9.80%2.67B | 48.50%12.33B | 45.83%5.03B | --2.4B | 75.18%2.47B | -31.90%2.43B | -36.40%8.3B | -51.97%3.45B |
| Total other operating income | 12.61%2.97B | -18.51%11.72B | -56.99%2.64B | 30.24%14.38B | -9.40%2.68B | -36.27%2.26B | 36.57%3.3B | 173.25%6.14B | 50.06%11.04B | 83.49%2.96B |
| Operating profit | -36.06%12.72B | -12.49%75.74B | -4.91%19.89B | -26.37%86.54B | 21.32%15.59B | -14.41%24.24B | -20.02%25.8B | -52.58%20.92B | 37.77%117.54B | -48.25%12.85B |
| Net non-operating interest income (expenses) | -4.32%-2.39B | 4.34%-10.9B | -13.56%-2.29B | -74.14%-11.39B | -16.77%-3.27B | -24.56%-3.31B | -291.73%-2.79B | -440.11%-2.02B | -121.27%-6.54B | -564.22%-2.8B |
| Non-operating interest income | 22.73%4.42B | 24.63%14.87B | 16.29%3.6B | -6.83%11.93B | -20.20%2.84B | -16.07%2.8B | -4.60%3.19B | 21.05%3.09B | 72.42%12.8B | 66.78%3.56B |
| Non-operating interest expense | 7.31%6.7B | 10.43%26.51B | 13.09%6.24B | 29.50%24.01B | 19.43%6.83B | 17.44%5.73B | 34.89%5.93B | 55.72%5.52B | 65.36%18.54B | 93.93%5.72B |
| Total other finance cost | 132.85%114M | -8.77%-744M | 13.90%-347M | -184.65%-684M | -210.03%-713M | -66.22%375M | 116.96%57M | 34.26%-403M | 197.58%808M | 266.15%648M |
| Net investment income | 46.01%2.32B | 33.00%7.38B | 19.09%1.59B | -17.63%5.55B | -72.25%909M | 128.89%2.71B | -11.16%589M | -16.97%1.34B | 32.96%6.73B | 232.25%3.28B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 25.30%10.8B | 13.78%49.63B | 0.55%8.62B | 59.87%43.62B | 247.28%14.45B | -10.96%10.89B | -31.81%9.69B | -19.46%8.58B | -28.14%27.28B | -178.36%-9.81B |
| Special income (charges) | -62.74%1.5B | 1,034.04%13.46B | 278.13%4.01B | -88.17%1.19B | -130.97%-1.88B | 476.30%651M | 426.81%1.35B | -76.66%1.06B | 223.99%10.03B | 208.29%6.07B |
| Less:Impairment of capital assets | --2M | -81.58%918M | --0 | -65.25%4.98B | -61.64%4.6B | -98.96%22M | 122.22%60M | 47.34%305M | 443.72%14.34B | 840.27%11.98B |
| Less:Other special charges | 62.69%-1.5B | -133.05%-14.38B | -193.70%-4.01B | 74.68%-6.17B | 84.96%-2.72B | 65.50%-673M | -465.12%-1.41B | 71.26%-1.37B | -546.89%-24.37B | -516.67%-18.05B |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -21.61%24.95B | 7.81%135.3B | 6.54%31.82B | -19.05%125.5B | 169.27%25.8B | -9.56%35.18B | -24.71%34.64B | -50.66%29.87B | 32.18%155.04B | -70.35%9.58B |
| Income tax | -62.29%2.99B | -5.95%21.1B | 11.34%7.93B | -42.78%22.44B | -97.52%163M | -6.38%7.21B | -23.80%7.95B | -50.90%7.12B | 23.21%39.21B | -44.89%6.58B |
| Net income | -8.10%21.95B | 10.81%114.2B | 5.03%23.89B | -11.02%103.06B | 753.56%25.64B | -10.35%27.98B | -24.98%26.69B | -50.59%22.75B | 35.51%115.82B | -85.26%3B |
| Net income continuous operations | -8.10%21.96B | 10.81%114.2B | 5.04%23.89B | -11.02%103.06B | 753.28%25.64B | -10.35%27.98B | -24.98%26.7B | -50.59%22.75B | 35.51%115.83B | -85.26%3.01B |
| Noncontrolling interests | 3.55%875M | 55.27%3.56B | 39.67%845M | -49.88%2.29B | -81.39%91M | -48.52%697M | -51.48%900M | -31.17%605M | 45.86%4.58B | 560.81%489M |
| Net income attributable to the company | -8.53%21.08B | 9.80%110.64B | 4.08%23.04B | -9.42%100.77B | 915.50%25.55B | -8.62%27.28B | -23.52%25.79B | -50.96%22.14B | 35.12%111.25B | -87.61%2.52B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -8.53%21.08B | 9.80%110.64B | 4.08%23.04B | -9.42%100.77B | 915.50%25.55B | -8.62%27.28B | -23.52%25.79B | -50.96%22.14B | 35.12%111.25B | -87.61%2.52B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.45%100.3 | 13.92%513.74 | 9.52%106.08 | -6.43%450.97 | 962.75%115.84 | -98.98%123.3 | -98.74%115.39 | -50.48%96.86 | 36.66%481.94 | -87.61%10.9 |
| Diluted earnings per share | -5.45%100.3 | 13.92%513.74 | 9.52%106.08 | -6.43%450.97 | 962.75%115.84 | -98.98%123.3 | -98.74%115.39 | -50.48%96.86 | 36.66%481.94 | -87.61%10.9 |
| Dividend per share | 0 | 11.11%150 | 0 | 3.85%135 | 7.69%70 | 0 | 0.00%65 | 0 | 35.42%130 | 6.56%65 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |